CARDIAC MARKERS
Cardiac biomarkers have become essential cardiology tools over the last 50 years, that is to say for primary and secondary prevention, diagnosis and support for acute myocardial infarction Heart Type Fatty Acid-Binding Protein (H-FABP) & Troponin I (CTNI) Combo (IAM) and the diagnosis and stratification of the risk of heart failure (IH).
We enter an era where it may be possible for biomarkers to direct treatment to optimize patient care. This is already the case with the cardiac troponin (CTN) but should be the goal with all biomarkers. This special issue is a compilation of current journals and original articles on this subject
CARDIAC MARKERS
Cardiac biomarkers have become essential cardiology tools over the last 50 years, that is to say for primary and secondary prevention, diagnosis and support for acute myocardial infarction Heart Type Fatty Acid-Binding Protein (H-FABP) & Troponin I (CTNI) Combo (IAM) and the diagnosis and stratification of the risk of heart failure (IH).
We enter an era where it may be possible for biomarkers to direct treatment to optimize patient care. This is already the case with the cardiac troponin (CTN) but should be the goal with all biomarkers. This special issue is a compilation of current journals and original articles on this subject
TROPONIN I (cTnI)
CK-MB
MYOGLOBIN
HEART TYPE FATTY ACID-BINDING PROTEIN H-FABP
HEART TYPE FATTY ACID-BINDING PROTEIN (H-FABP) & TROPONIN I (cTnI) COMBO
MYOGLOBIN, CK-MB & TROPONIN I COMBO
HEART TYPE FATTY ACID-BINDING PROTEIN (H-FABP) & MYOGLOBIN / CK-MB / TROPONIN I COMBO
NT-proBNP
D-DIMER
C REACTIVE PROTEIN
PROCALCITONIN (PCT)
◼︎ CONTACT US NOW ◼︎
CARDIAC MARKERS CATALOG
Soon available for download
